Position in GRFS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$207,132
-$270,731 QoQ
Shares Held
29,256
-50.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 164 holders
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 66%
Shared 0%
None 34%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Orion Porfolio Solutions, LLC holds $237,611,307 across 15 Drug Manufacturers - General names. GRFS ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,486 | $61,753,858 | |
| 2 | JNJ |
Johnson & Johnson
|
228,001 | $57,905,413 | |
| 3 | ABBV |
AbbVie Inc.
|
130,643 | $32,875,004 | |
| 4 | AZN |
Astrazeneca PLC
|
89,022 | $16,880,351 | |
| 5 | MRK |
Merck & Co., Inc.
|
119,842 | $15,399,697 | |
| 6 | PFE |
Pfizer Inc
|
419,584 | $10,103,582 | |
| 7 | NVS |
Novartis AG
|
58,960 | $9,240,211 | |
| 8 | AMGN |
Amgen Inc
|
24,477 | $8,863,611 |
All Filings in GRFS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $207,132 | 29,256 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $477,863 | 59,584 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $363,116 | 38,836 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $427,184 | 42,890 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $259,836 | 28,743 | Shares | Sole | 2025-08-27 | |
| 2025-03-31 | $111,399 | 15,668 | Shares | Sole | 2025-08-01 | |
| 2024-12-31 | $118,697 | 15,954 | Shares | Sole | 2025-08-01 | |
| 2023-06-30 | $93,688 | 10,228 | Shares | Sole | 2025-07-31 | |
| 2022-09-30 | $68,517 | 11,123 | Shares | Sole | 2022-11-01 | |
| No filing history on record for this holder in this stock. | ||||||